Immuneering Corp. (IMRX)

4.98 -0.24 (-4.60%) USD  |  NASDAQ  |  Mar 27, 14:38
More

Immuneering Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade